News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer
May 21, 2024, 12:45

Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer

Enrique Grande, Head of the Medical Oncology Service and Director of Clinical Research at the MD Anderson Cancer Center Madrid Foundation, shared on X/Twitter:

“On Nature – Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer.”

Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer

Visit the article website.
Source: Enrique Grande/X

antitumor immune response cancer Enrique Grande MD Anderson Cancer Center muscle invasive bladder cancer Nature neoadjuvant chemotherapy OncoDaily Oncology Pathological complete response regulatory T cells
Special Coverage
Blog
Apr 11, 2025, 18:17
Michael Sapienza: Excited to Join the 2025 Screen Smart Dinner as a Panelist and Advisory Committee Member
Blog
Apr 11, 2025, 18:03
Tirzah Petta has been appointed as Director of the USC Norris Molecular Genomics Core
Blog
Apr 11, 2025, 17:57
David Planchard: Beating Durvalumab Monotherapy Post-CRT in Unresectable Stage III NSCLC
Blog
Apr 11, 2025, 17:51
Zoe Betancourt: Though ASCO Advocacy Summit is over, it’s not too late to take part in ASCO’s Week of Action
Blog
Apr 11, 2025, 17:43
Yan Leyfman: What happens after patients stop taking GLP-1 receptor agonists
Blog
Apr 11, 2025, 17:37
Lorenza Rimassa: Grateful to have worked on systemic therapy research for cholangiocarcinoma and biliary tract cancer
Blog
Apr 11, 2025, 17:27
Mark Hughes Foundation Centre for Brain Cancer Research Announces Six MHF Innovation Grant Recipients
Blog
Apr 11, 2025, 17:22
Antonio Passaro: Discussed the evolving treatment landscape for patients with EGFR-mutant NSCLC at ISCO25
Science
Apr 11, 2025, 16:22
Amar U Kishan: Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer 
Blog
Apr 11, 2025, 15:47
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Opinion
Apr 11, 2025, 15:22
Amol Akhade Highlights Tarlatamab’s OS Benefit in SCLC
Blog
Apr 11, 2025, 15:01
Joseph Vento: ASCO update on PARPi and ARPI therapy in BRCA-mut mHRPC with Tian Zhang